W.R. Berkley Corp’s Albany Molecular Research Inc AMRI Stock Holding History

W.R. Berkley Corp’s Portfolio AMRI Stock Details AMRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-96,890	Closed	-$2.1M	–	102
2017 Q2	$2.1M	Buy	+96,890	New	+$1.76M	0.22%	54

Other funds holding AMRI

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

W.R. Berkley Corp's AMRI Position: Q3 2017 in Review

W.R. Berkley Corp sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 96,890 shares — an estimated $2.1M sold.

W.R. Berkley Corp first reported a position in AMRI in Q2 2017 and held it in 1 quarter. The position peaked at $2.1M in Q2 2017. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

W.R. Berkley Corp reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
W.R. Berkley Corp sold 96,890 Albany Molecular Research Inc shares in Q3 2017, an estimated $2.1M.
W.R. Berkley Corp first reported a position in Albany Molecular Research Inc in Q2 2017 and held it in 1 quarter.
W.R. Berkley Corp's Albany Molecular Research Inc position peaked at $2.1M in Q2 2017.
2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on W.R. Berkley Corp's 13F filing for Q3 2017, filed 14 Nov 2017.